NCT04487236 2025-08-11Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid TumorsSuzhou Zanrong Pharma LimitedPhase 1 Completed61 enrolled
NCT02000882 2022-02-07STAR Cape+BKM120 MBC With Brain MetUS Oncology ResearchPhase 2 Completed10 enrolled 11 charts
NCT02260531 2021-05-20Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain MetastasesDana-Farber Cancer InstitutePhase 2 Completed36 enrolled 19 charts
NCT00820222 2019-04-02Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerNovartisPhase 3 Completed540 enrolled 18 charts
NCT01386580 2015-01-22An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.BBB-Therapeutics B.V.Phase 1/2 Completed84 enrolled
NCT00005842 2013-02-11Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed24 enrolled